A Randomized, Double-blind, Double-dummy, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Different Doses of Indacaterol in Adult Patients With Persistent Asthma, Using Salmeterol as an Active Control.
Phase of Trial: Phase III
Latest Information Update: 22 Jul 2011
At a glance
- Drugs Indacaterol; Salmeterol
- Indications Asthma
- Focus Therapeutic Use
- 22 Jul 2011 Last checked against ClinicalTrials.gov record.
- 29 Jul 2010 Actual end date added to 1 Jul 2010 as reported by ClinicalTrials.gov.
- 29 Jul 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.